Journal profile · Otorhinolaryngology
Auris Nasus Larynx
ISSN 0385-8146 · eISSN 1879-1476 · Elsevier Ireland Ltd · NETHERLANDS · Quarterly · Founded 1973
Auris Nasus Larynx: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.73; hybrid open access; APC about USD 3,520; median 96 days to acceptance (101 articles, last 24 months); community-reported acceptance: easy (Elsevier website: 24%); 144 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Auris Nasus Larynx is published by Elsevier Ireland Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Vestibular and auditory disorders, Ear Surgery and Otitis Media and Hearing, Cochlea, Tinnitus, Genetics, together about 26.9% of its articles. Its main subfields are Otorhinolaryngology. (generated from OpenAlex topic counts and CAS ranking data)
The Official Journal of the Japanese Society of Otorhinolaryngology-Head and Neck Surgery. The international journal Auris Nasus Larynx provides the opportunity for rapid, carefully reviewed publications concerning the fundamental and clinical aspects of otorhinolaryngology and related fields. This includes otology, neurotology, bronchoesophagology, laryngology, rhinology, allergology, head and neck medicine and oncologic surgery, maxillofacial and plastic surgery, audiology, speech science.Original papers, short communications and original case reports can be submitted. Reviews on recent developments are invited regularly and Letters to the Editor commenting on papers or any aspect of Auris Nasus Larynx are welcomed.Founded in 1974 and previously published by the Society for Promotion of International Otorhinolaryngology, the journal is now the official English-language journal of the Japanese Society of Otorhinolaryngology-Head and Neck Surgery. The aim of its new international Editorial Board is to make Auris Nasus Larynx an international forum for high quality research and clinical sciences.
From the journal's Aims & Scope
Research area (LetPub): Otorhinolaryngology
Editor-in-chief Shinichi IwasakiPublisher website
Editorial board by country: none in mainland China; most named Japan 43, United States 14, South Korea 6, Taiwan, China 2, Germany 2 (75 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Vestibular and auditory disordersNeuroscience9.5%
- Ear Surgery and Otitis MediaMedicine9.5%
- Hearing, Cochlea, Tinnitus, GeneticsNeuroscience7.9%
- Head and Neck Cancer StudiesMedicine5.8%
- Sinusitis and nasal conditionsMedicine5.8%
- Head and Neck Surgical OncologyMedicine5.7%
- Ear and Head TumorsMedicine4.9%
- Voice and Speech DisordersMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Otorhinolaryngology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Otorhinolaryngology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Otorhinolaryngology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.73LetPub ·
- Impact factor (publisher)
- 1.8Publisher website ·
- CiteScore 2026-06
- 3.2LetPub ·
- CiteScore (publisher)
- 3.2Publisher website ·
- SJR 2026-06
- 0.59LetPub ·
- SNIP 2026-06
- 1.06LetPub ·
- h-index
- 41LetPub ·
- h-index
- 77OpenAlex ·
- i10-index
- 2,159OpenAlex ·
- 2-year mean citedness
- 1.98OpenAlex ·
- Self-citation rate
- 11.1%LetPub ·
- Share of gold OA articles
- 17.22%LetPub ·
Volume
- Articles per year
- 125LetPub ·
Articles by year OpenAlex count · 4,755 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 112 | 46 | 17 |
| 2025 | 144 | 75 | 249 |
| 2024 | 115 | 58 | 467 |
| 2023 | 109 | 56 | 644 |
| 2022 | 146 | 71 | 1,063 |
| 2021 | 187 | 60 | 1,570 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 74 days – 128 days
- Acceptance to online
- median 14 days (101 articles)
- Submission to online
- median 115 days
- Sample
- 101 articles with submission and acceptance dates (275 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- 24%LetPub ·
- Acceptance rate (publisher)
- 15%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 29 daysPublisher website ·
- Submission to acceptance
- 96 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,520 / EUR 3,290 / GBP 2,820 / JPY 436,590 | — | — | |
| Publisher website | USD 3,520 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 400 words
- Keywords
- ≥ 3
- Reference style
- Vancouver
Article types accepted9
- case reportOriginal papers and original case reports can be submitted. Thorough and detailed reviews on recent developments and Letters to the Editor commenting on papers …Length not stated
- correspondenceOriginal papers and original case reports can be submitted. Thorough and detailed reviews on recent developments and Letters to the Editor commenting on papers …Length not stated
- letters to the editorOriginal papers and original case reports can be submitted. Thorough and detailed reviews on recent developments and Letters to the Editor commenting on papers …Length not stated
- original case reportsOriginal papers and original case reports can be submitted.Length not stated
- original paperOriginal papers and original case reports can be submitted. Thorough and detailed reviews on recent developments and Letters to the Editor commenting on papers …Length not stated
- original papersOriginal papers and original case reports can be submitted.Length not stated
- original researchOriginal papers and original case reports can be submitted. Thorough and detailed reviews on recent developments and Letters to the Editor commenting on papers …Length not stated
- reviewOriginal papers and original case reports can be submitted. Thorough and detailed reviews on recent developments and Letters to the Editor commenting on papers …Length not stated
- reviewsThorough and detailed reviews on recent developments and Letters to the Editor commenting on papers or any aspect of the Journal are welcomed.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: 1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; 2) Drafting the work or revising it critically for important intellectual content; 3) Final approval of the version to be published; 4) Agreement to be accountable for all aspects …
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: Employment Consultancies Stock ownership Honoraria Paid expert testimony Patent applications or registrations Grants or any other funding Affiliation with the journal as an Editor or Advisor…
Source ↗Publisher website ·- Publication ethics Ethical Standards
Ethical standards for human subjects Model summary
Any investigation on human subjects must be in accordance with the Code of Ethics of the World Medical Association (Helsinki Declaration). Auris Nasus Larynx requires authors to state in the Method section that the protocol of the investigation has been approved by the Institutional Review Board, and that the investigators have obtained written informed consent from each participant or each partic…
Source ↗Publisher website ·- License & copyright Submission of Manuscripts: Originality and Copyright
Submission of an article is understood to imply that the article is original and is not being considered for publication elsewhere. Upon acceptance of the article by the journal, the author(s) will be asked to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible dissemination of information.
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trial registration required Model summary
Any clinical trial must be registered in a publicly accessible database.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ireland Ltd
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 1973
- ISSN
- 0385-8146
- Electronic ISSN
- 1879-1476
- Society / sponsor
- Japanese Society of Otorhinolaryngology-Head and Neck Surgery
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Auris Nasus Larynx
What CAS zone is Auris Nasus Larynx in?
In the 2025 upgraded edition of the CAS Journal Ranking, Auris Nasus Larynx is in Zone 4 of Medicine, and in Zone 3 of the minor category Otorhinolaryngology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Auris Nasus Larynx?
The latest impact factor listed by LetPub is 1.73; CiteScore 3.2, h-index 77.
How long does peer review take at Auris Nasus Larynx?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 74–128 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy (Elsevier website: 24%)”; the journal's website gives an acceptance rate of 15%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Auris Nasus Larynx?
According to the journal's author guidelines: Abstract: ≤ 400 words; Keywords: ≥ 3; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Auris Nasus Larynx based?
Of the 75 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Japan (43), United States (14) and South Korea (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Auris Nasus Larynx?
According to LetPub and DOAJ records, Auris Nasus Larynx is indexed in SCIE and Scopus.
Is Auris Nasus Larynx open access, and what is the APC?
Auris Nasus Larynx is a hybrid journal. For open-access publication: APC about USD 3,520.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .